Algae-Based Biopharmaceuticals

Nonfiction, Science & Nature, Science, Biological Sciences, Botany, Ecology
Cover of the book Algae-Based Biopharmaceuticals by Sergio Rosales-Mendoza, Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Sergio Rosales-Mendoza ISBN: 9783319322322
Publisher: Springer International Publishing Publication: May 21, 2016
Imprint: Springer Language: English
Author: Sergio Rosales-Mendoza
ISBN: 9783319322322
Publisher: Springer International Publishing
Publication: May 21, 2016
Imprint: Springer
Language: English

This book constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.

This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. 

First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.

This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. 

First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.

More books from Springer International Publishing

Cover of the book Serious Games by Sergio Rosales-Mendoza
Cover of the book Economic Diversification and Growth in Africa by Sergio Rosales-Mendoza
Cover of the book Advances in Artificial Intelligence: From Theory to Practice by Sergio Rosales-Mendoza
Cover of the book African Diaspora Direct Investment by Sergio Rosales-Mendoza
Cover of the book Machines, Computations, and Universality by Sergio Rosales-Mendoza
Cover of the book Marine Fog: Challenges and Advancements in Observations, Modeling, and Forecasting by Sergio Rosales-Mendoza
Cover of the book Ionic Liquid Properties by Sergio Rosales-Mendoza
Cover of the book Information Security Practice and Experience by Sergio Rosales-Mendoza
Cover of the book Environmental Management in Ski Areas by Sergio Rosales-Mendoza
Cover of the book Religion and the American Presidency by Sergio Rosales-Mendoza
Cover of the book Laughter, Literature, Violence, 1840–1930 by Sergio Rosales-Mendoza
Cover of the book Big Data for Urban Sustainability by Sergio Rosales-Mendoza
Cover of the book Shale Analytics by Sergio Rosales-Mendoza
Cover of the book Technosex by Sergio Rosales-Mendoza
Cover of the book The Functional Nucleus by Sergio Rosales-Mendoza
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy